End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2986 USD | +3.68% | -0.47% | -54.76% |
May. 17 | Senti Biosciences, Inc. Announces Executive Changes | CI |
May. 09 | Senti Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 48
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Next-generation Cell and Gene Therapies
100.0
%
| 4 | 100.0 % | 3 | 100.0 % | -40.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 3 | 100.0 % | -40.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Lu
FOU | Founder | 43 | 16-06-08 |
Kanya Rajangam
PSD | President | 50 | 22-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Berland
BRD | Director/Board Member | 69 | 21-05-31 |
Director/Board Member | 64 | 16-06-30 | |
Omid Farokhzad
BRD | Director/Board Member | 55 | 22-06-07 |
James Collins
BRD | Director/Board Member | 58 | 22-06-07 |
Thomas P. Chung
BRD | Director/Board Member | - | 22-08-31 |
Timothy Lu
FOU | Founder | 43 | 16-06-08 |
Director/Board Member | 59 | 19-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,755,021 | 36,136,724 ( 78.98 %) | 0 | 78.98 % |
Company contact information
Senti Biosciences, Inc.
2 Corporate Drive First Floor
94080, South San Francisco
+
http://www.sentibio.comSector
1st Jan change | Capi. | |
---|---|---|
-54.76% | 12.84M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- SNTI Stock
- Company Senti Biosciences, Inc.